Jun 29, 2026
15 MIN READ

Wegovy for Weight Loss: What Dose Truly Starts Working?

Semaglutide typically shows measurable weight loss within 4 weeks of starting treatment, with stronger results appearing by week 8–12. Dose escalation follows a structured schedule, but individual response varies based on genetics and metabolism.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 29, 2026
15 MIN READ

wegovy for weight loss: what dose truly starts working? — PlexusDx GLP-1 education

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people wonder how long semaglutide takes to work and at what dose meaningful weight loss begins. Clinical trials show that semaglutide reduces appetite and increases satiety within the first two weeks, though visible weight loss often appears between weeks 4 and 8 depending on starting dose, individual metabolism, and adherence to a structured eating plan.

How Semaglutide Works and Initial Response Timeline

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone controlling hunger and blood sugar. Within 48 to 72 hours of your first injection, most users report reduced appetite and changes in food cravings, even at a low starting dose. These neurological changes happen before significant weight loss occurs, which is why appetite suppression is often the first noticeable effect.

Visible weight loss typically appears between days 21 and 28 of treatment, though the exact timeline depends on your starting dose and individual metabolism. By week 8 to 12, most patients report losing 5–10% of their starting body weight if they combine medication with consistent dietary changes and physical activity. The gradient of response means some users see results earlier, while others need 12–16 weeks to reach their initial weight loss goals.

Dose Escalation Schedules and Effectiveness Plateaus

Semaglutide treatment follows a dose-escalation protocol designed to minimize side effects while building therapeutic response. Most programs start at 0.25 mg per week and increase every 4 weeks up to a maintenance dose of 1.0 mg or 2.0 mg per week. This gradual climb allows your body to adjust to the medication and helps you identify your optimal effective dose without overwhelming gastrointestinal effects.

Each dose level produces its own weight loss response curve. Early doses (0.25–0.5 mg) typically reduce hunger and stabilize weight within 4–8 weeks. Mid-range doses (0.75–1.0 mg) often trigger more aggressive appetite suppression and weight loss of 1–2 pounds per week in compliant patients. Higher doses (1.5–2.0 mg) may produce steeper results in some individuals, though diminishing returns become apparent after 12–16 weeks at any given dose level.

Genetic Factors Influencing Individual Dose Response

Your genetic makeup directly influences how your body responds to semaglutide and at what dose you'll see optimal results. Key genetic variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) affect receptor sensitivity, hormone signaling, and baseline metabolic rate. These differences explain why identical semaglutide doses produce different weight loss outcomes in different people.

PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and 49 peptides to reveal your specific genetic predispositions for GLP-1 sensitivity and weight loss response. Understanding your genetic profile helps clinicians predict whether you'll respond best to lower, moderate, or higher semaglutide doses, and whether combination therapy might serve you better than monotherapy. This personalized approach accelerates your path to an effective dose rather than relying on trial-and-error escalation.

Comparing Compounded Semaglutide to Brand Options

Brand-name Wegovy and compounded semaglutide from licensed 503A pharmacies contain the same active compound and follow the same pharmacological dosing principles. Both require weekly injections and use identical dose escalation schedules. The clinical effectiveness of compounded semaglutide is equivalent to branded versions, with similar onset timelines and response curves at each dose level.

PlexusDx compounded semaglutide injection starts at $149 per month with no flat per-compound pricing changes—your dose may increase, but your price won't. Compounded semaglutide from licensed 503A pharmacies is available in all 50 states without insurance requirements, and the medication is eligible for HSA and FSA accounts. This accessibility means more people can begin treatment at lower cost while maintaining clinical quality and response predictability.

Maximizing Semaglutide Effectiveness Beyond Dosing

Semaglutide's weight loss effect amplifies when combined with structured nutrition, consistent physical activity, and adequate sleep. The medication suppresses appetite, but you must actively choose nutrient-dense foods and hydrate sufficiently to prevent muscle loss during weight reduction. Protein intake of 0.8–1.0 grams per pound of body weight preserves lean mass while semaglutide drives fat loss.

Patience with dose escalation and weight loss plateaus is essential for long-term success. Most individuals lose aggressively for the first 3–4 months, then experience a slowdown as their body adapts to the lower calorie intake and the medication dose reaches steady state. Adding resistance training, increasing daily steps, and consulting a dietitian familiar with GLP-1 therapy can push through these plateaus without increasing medication dose prematurely.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

At what semaglutide dose will I start losing weight?

Appetite reduction begins within 48–72 hours of your first injection, even at the starting 0.25 mg dose. Visible weight loss typically appears within 3–4 weeks. Most people need to reach at least 0.5–0.75 mg per week to see consistent 1–2 pound weekly losses, though your genetic profile influences the dose needed for optimal response.

How long does it take semaglutide to reach full effectiveness?

Full effectiveness emerges around week 12–16 of consistent treatment, as your dose reaches maintenance levels and your body adapts to appetite suppression. Peak weight loss typically occurs between months 4 and 6. Some individuals continue losing weight for 12+ months if they maintain medication adherence and dietary discipline.

Why does PlexusDx compounded semaglutide cost less than Wegovy?

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which operate at lower overhead than large pharmaceutical manufacturers. Compounded semaglutide is clinically identical to brand Wegovy but eliminates middleman costs. Pricing starts at $149 per month, flat across all dose levels, with no insurance or membership required.

Can I predict whether low or high semaglutide doses will work better for me?

The Precision Peptide Genetic Test from PlexusDx analyzes genetic variants in your GLP1R, GIPR, FTO, and MC4R genes to predict your dose sensitivity and overall weight loss potential. This personalized insight helps your clinician select your starting dose strategy and anticipate whether you'll benefit from dose escalation, combination therapy, or microdose protocols.

Is compounded semaglutide as safe as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains identical active pharmaceutical ingredients to Wegovy and undergoes the same quality and sterility standards. Both formulations carry the same potential side effects (nausea, constipation, dehydration) and contraindications. Clinical safety profiles are equivalent across compounded and branded semaglutide at all dose levels.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves